List of works - Denis A. Babkov

5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis

scientific article published on 9 June 2015

6-Nitroazolo[1,5-a]pyrimidin-7(4H)-ones as Antidiabetic Agents.

scientific article published on 20 November 2017

An Efficient Route to Novel Uracil-Based Drug-Like Molecules

article published in 2015

Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.

scientific article published on 19 April 2018

Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase.

scientific article published on 25 September 2017

Evaluation of Cytotoxicity and α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids

scientific article published on 20 October 2020

N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase.

scientific article published on 3 January 2013

Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents

scientific article published on 25 October 2019

Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.

scientific article published on 22 November 2017

Scaffold hopping: exploration of acetanilide-containing uracil analogues as potential NNRTIs

scientific article

Structural modifications of 2,3-indolobetulinic acid: Design and synthesis of highly potent α-glucosidase inhibitors

scientific article published on 29 April 2019

Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents

scientific article

Synthesis and anti-HCMV activity of 1-[ω-(phenoxy)alkyl]uracil derivatives and analogues thereof

scientific article published on 16 May 2013

Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.

scientific article published on 6 June 2017

Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors

scientific article published on 15 March 2019

Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors

scientific article published on 12 October 2018

Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides.

scientific article

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators

scientific article published on 23 July 2019

List of works by Denis A. Babkov

5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis

6-Nitroazolo[1,5-a]pyrimidin-7(4H)-ones as Antidiabetic Agents.

An Efficient Route to Novel Uracil-Based Drug-Like Molecules

Author Correction: Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.

Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase.

Evaluation of Cytotoxicity and α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids

N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase.

Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents

Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.

Scaffold hopping: exploration of acetanilide-containing uracil analogues as potential NNRTIs

Structural modifications of 2,3-indolobetulinic acid: Design and synthesis of highly potent α-glucosidase inhibitors

Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents

Synthesis and anti-HCMV activity of 1-[ω-(phenoxy)alkyl]uracil derivatives and analogues thereof

Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.

Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors

Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors

Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides.

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators